Allred DC - Search Results

1

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.

Albain KS, Barlow WE, Shak S, Hortobagyi GN, Livingston RB, Yeh IT, Ravdin P, Bugarini R, Baehner FL, Davidson NE, Sledge GW, Winer EP, Hudis C, Ingle JN, Perez EA, Pritchard KI, Shepherd L, Gralow JR, Yoshizawa C, Allred DC, Osborne CK, Hayes DF; Breast Cancer Intergroup of North America. Albain KS, et al. Among authors: allred dc. Lancet Oncol. 2010 Jan;11(1):55-65. doi: 10.1016/S1470-2045(09)70314-6. Epub 2009 Dec 10. Lancet Oncol. 2010. PMID: 20005174 Free PMC article.

2

Prognosis and treatment decisions in patients with breast cancer without axillary node involvement.

McGuire WL, Tandon AK, Allred DC, Chamness GC, Ravdin PM, Clark GM. McGuire WL, et al. Among authors: allred dc. Cancer. 1992 Sep 15;70(6 Suppl):1775-81. doi: 10.1002/1097-0142(19920915)70:4+<1775::aid-cncr2820701619>3.0.co;2-8. Cancer. 1992. PMID: 1355403

3

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.

Allred DC, Clark GM, Tandon AK, Molina R, Tormey DC, Osborne CK, Gilchrist KW, Mansour EG, Abeloff M, Eudey L, et al. Allred DC, et al. J Clin Oncol. 1992 Apr;10(4):599-605. doi: 10.1200/JCO.1992.10.4.599. J Clin Oncol. 1992. PMID: 1548522 Clinical Trial.

4

Treatment decisions in axillary node-negative breast cancer patients.

McGuire WL, Tandon AK, Allred DC, Chamness GC, Ravdin PM, Clark GM. McGuire WL, et al. Among authors: allred dc. J Natl Cancer Inst Monogr. 1992;(11):173-80. J Natl Cancer Inst Monogr. 1992. PMID: 1627425 Clinical Trial.

5

Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen.

Osborne CK, Coronado E, Allred DC, Wiebe V, DeGregorio M. Osborne CK, et al. Among authors: allred dc. J Natl Cancer Inst. 1991 Oct 16;83(20):1477-82. doi: 10.1093/jnci/83.20.1477. J Natl Cancer Inst. 1991. PMID: 1920493

6

Immunohistochemical studies of early breast cancer evolution.

Allred DC, O'Connell P, Fuqua SA, Osborne CK. Allred DC, et al. Breast Cancer Res Treat. 1994;32(1):13-8. doi: 10.1007/BF00666202. Breast Cancer Res Treat. 1994. PMID: 7819582 Review.

7

Molecular genetic studies of early breast cancer evolution.

O'Connell P, Pekkel V, Fuqua S, Osborne CK, Allred DC. O'Connell P, et al. Among authors: allred dc. Breast Cancer Res Treat. 1994;32(1):5-12. doi: 10.1007/BF00666201. Breast Cancer Res Treat. 1994. PMID: 7819586 Review.

8

Breast cancer outcome and predictors of outcome: are there age differentials?

Albain KS, Allred DC, Clark GM. Albain KS, et al. Among authors: allred dc. J Natl Cancer Inst Monogr. 1994;(16):35-42. J Natl Cancer Inst Monogr. 1994. PMID: 7999467

9

Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancer.

Ravdin PM, Tandon AK, Allred DC, Clark GM, Fuqua SA, Hilsenbeck SH, Chamness GC, Osborne CK. Ravdin PM, et al. Among authors: allred dc. J Clin Oncol. 1994 Mar;12(3):467-74. doi: 10.1200/JCO.1994.12.3.467. J Clin Oncol. 1994. PMID: 8120545

10

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer.

Allred DC, Clark GM, Elledge R, Fuqua SA, Brown RW, Chamness GC, Osborne CK, McGuire WL. Allred DC, et al. J Natl Cancer Inst. 1993 Feb 3;85(3):200-6. doi: 10.1093/jnci/85.3.200. J Natl Cancer Inst. 1993. PMID: 8423624

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

173 results

Search Page